OBJECTIVE Significant others are central to patients' experience and management of their cancer illness. Building on our validation of the Distress Thermometer (DT) for family members, this investigation examines individual and collective distress in a sample of cancer patients and their matched partners, accounting for the aspects of gender and role. METHOD Questionnaires including the DT we...

Fatigue is a common, significant problem in patients receiving cancer treatment. About 80%–100% of patients with cancer report some degree of fatigue (Nail, 2002; Ream & Richardson, 1999). Similar to pain, fatigue is a subjective, complex experience. Patients may report feelings of fatigue despite the use of erythropoietin therapy to increase or maintain their hemoglobin levels. In an effort to...

Objective: The aim of the study was to prescription pattern prophylactic antiemetics in breast cancer patients. Methods: A retrospective observational carried out. Over a period 3 months, all chemotherapy order sheets patients were collected and evaluated for prophylaxis chemotherapy-induced nausea vomiting (CINV). We compared each antiemetic drug used CINV with international guidelines, Nation...

Chronic lymphocytic leukemia/small lymphoma (CLL/SLL) is characterized by the accumulation of abnormal lymphocytes in blood, bone marrow, and lymphoid tissues, leading to a weakened immune system an increased risk infections for patients. The NCCN Guidelines CLL/SLL underscore need comprehensive evaluation multiple factors determine most appropriate treatment approach each patient. For frontlin...